APPLICATION OF LITCHI CHINENSIS PERICARP EXTRACT MAINLY COMPOSED OF POLYMER POLYPHENOLS IN PREPARATION OF ALPHA AMYLASE INHIBITOR
20210379135 · 2021-12-09
Assignee
Inventors
Cpc classification
A01P1/00
HUMAN NECESSITIES
A61K2236/51
HUMAN NECESSITIES
A61K36/77
HUMAN NECESSITIES
International classification
Abstract
The present invention discloses an application of litchi chinensis pericarp extract mainly composed of polymer polyphenols in preparation of α-amylase inhibitor, which belongs to the technical field of biology. The litchi chinensis pericarp extract mainly composed of polymer polyphenols disclosed by the present invention has a very good inhibitory effect on α-amylase, whereas α-amylase is applied in weight and blood glucose reduction, biological pesticides, dental caries prevention, and osteoporosis prevention and treatment.
Claims
1. An application of litchi chinensis pericarp extract mainly composed of polymer polyphenols in preparation of α-amylase inhibitor.
2. The application of litchi chinensis pericarp extract mainly composed of polymer polyphenols in preparation of α-amylase inhibitor according to claim 1, wherein a method for preparing the litchi chinensis pericarp extract mainly composed of polymer polyphenols is as follows: (1) extracting fresh litchi chinensis pericarp and 80% ethanol water solution with a volume of 8 times of that of the fresh litchi chinensis pericarp twice at room temperature, soaking for 7 days each time, filtering, and merging the filtrate; (2) centrifuging the filtrate at 3,500 rpm for 10 minutes to collect a supernatant and obtain a drug solution; (3) purifying the drug solution by column chromatography through XDA-7 macroporous resin and eluting the drug solution by an ethanol water solution with a volume fraction of 60% to obtain an extract eluent; the column chromatography purification conditions are that: the mass concentration of loading buffer is 3.5 mg/mL, the pH value of the drug solution is 4.5, the sample loading rate is 4 BV/h, and the flow rate of the eluent is 6 BV/h; and (4) concentrating the extract eluent under reduced pressure at a vacuum degree of 95 kPa, a heating bath temperature of 40° C. and a cooling water temperature of 15° C., and spray-drying the resulting reflux liquid at a feeding rate of 51 mL/min, an inlet air temperature of 160° C., an exhaust air temperature of 60° C., a feed liquid concentration of 22%, and an atomizer rotating speed of 21,000 r/min to obtain the litchi chinensis pericarp extract.
3. The application of litchi chinensis pericarp extract mainly composed of polymer polyphenols in preparation of α-amylase inhibitor according to claim 1, wherein the litchi chinensis pericarp extract mainly composed of polymer polyphenols is applied in preparation of drugs for reducing weight, reducing blood glucose, preventing dental caries, and preventing and treating osteoporosis.
4. The application of litchi chinensis pericarp extract mainly composed of polymer polyphenols in preparation of α-amylase inhibitor according to claim 1, wherein the litchi chinensis pericarp extract mainly composed of polymer polyphenols is applied in preparation of biological pesticides.
Description
DESCRIPTION OF DRAWINGS
[0017] To more clearly describe the technical solution in the embodiments of the present invention or in the prior art, the drawings required to be used in the description of the embodiments or the prior art will be simply presented below. Apparently, the drawings in the following description are merely the embodiments of the present invention, and for those ordinary skilled in the art, other drawings can also be obtained according to the provided drawings without contributing creative labor.
[0018]
[0019]
DETAILED DESCRIPTION
[0020] The technical solution in the embodiments of the present invention will be clearly and fully described below in combination with the drawings in the embodiments of the present invention. Apparently, the described embodiments are merely part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments in the present invention, all other embodiments obtained by those ordinary skilled in the art without contributing creative labor will belong to the protection scope of the present invention.
Embodiment 1
[0021] A method for preparing the litchi chinensis pericarp extract, comprising the following specific steps:
[0022] Extracting fresh litchi chinensis pericarp and 80% ethanol water solution with a volume of 8 times of that of the fresh litchi chinensis pericarp twice at room temperature, soaking for 7 days each time, filtering, and merging the filtrate; centrifuging the filtrate at 3,500 rpm for 10 minutes to collect a supernatant and obtain a drug solution; purifying the drug solution by column chromatography through XDA-7 macroporous resin and eluting the drug solution by an ethanol water solution with a volume fraction of 60% to obtain an extract eluent; the column chromatography purification conditions are that: the mass concentration of loading buffer is 3.5 mg/mL, the pH value of the drug solution is 4.5, the sample loading rate is 4 BV/h, and the flow rate of the eluent is 6 BV/h; and concentrating the extract eluent under reduced pressure at a vacuum degree of 95 kPa, a heating bath temperature of 40° C. and a cooling water temperature of 15° C., and spray-drying the resulting reflux liquid at a feeding rate of 51 mL/min, an inlet air temperature of 160° C., an exhaust air temperature of 60° C., a feed liquid concentration of 22%, and an atomizer rotating speed of 21,000 r/min to obtain the litchi chinensis pericarp extract.
[0023] The content of polyphenols is determined by the Folin-phenol colorimetric method, and is 77.8%.
Embodiment 2
[0024] A component separation study is carried out to the litchi chinensis pericarp extract obtained from embodiment 1, and the specific operations are as follows:
[0025] Extracting the litchi chinensis pericarp extract obtained from embodiment 1 stepwise with n-hexane and ethyl acetate/anhydrous ether (1:1) to obtain an n-hexane phase, an ethyl acetate/anhydrous ether phase and a water phase of the litchi chinensis pericarp extract; and determining the total content of phenols in each of the three phases respectively. The results show that the total content of phenols in the water phase is the highest, followed by that in the ethyl acetate/anhydrous ether phase, and the total content of phenols in the n-hexane phase is the lowest (
Embodiment 3: Inhibitory Effect of the Litchi Chinensis Pericarp Extract Mainly Composed of Polymer Polyphenols on α-Amylase
[0026] (I) Preparation of Test Reagents
[0027] (1) Preparation of 0.01 Mol/L PBS Solution with pH=7.0:
[0028] Adding 61.0 ml of 0.2 mol/L disodium hydrogen phosphate, 39.0 ml of 0.2 mol/L sodium dihydrogen phosphate, and 0.8% sodium chloride solution to obtain 1 L of mixture, thus a 0.01 mol/L PBS buffer is obtained.
[0029] 0.2 mol/L disodium hydrogen phosphate: taking 35.81 g of Na.sub.2HPO.sub.4.12H.sub.2O, adding 500 ml of distilled water, and preserving after fully dissolved;
[0030] 0.2 mol/L sodium dihydrogen phosphate: taking 15.6 g of NaH.sub.2PO.sub.4.2H.sub.2O, adding 500 ml of distilled water, and preserving after fully dissolved; and
[0031] Preparation of 0.8% sodium chloride solution: taking 4 g of NaCl, adding 500 ml of distilled water, and preserving after fully dissolved.
[0032] (2) Preparation of 0.5% starch solution: taking 200 mg of soluble starch, dissolving the starch in 40 ml of 0.01 mol/L PBS buffer with pH=7.0, heating to make the starch dissolved, and preserving after fully dissolved.
[0033] (3) Preparation of α-amylase solution: adding α-amylase to 0.01 mol/L PBS buffer with pH=7.0 to prepare a 10 μg/ml solution, and preserving after fully dissolved.
[0034] (4) Preparation of DNS developer: taking 10.5 g of sodium hydroxide, adding an appropriate amount of water to dissolve the sodium hydroxide, taking 91.0 g of potassium sodium tartrate, adding an appropriate amount of water to dissolve the potassium sodium tartrate, heating properly to help dissolving if necessary, and blending the above two solutions uniformly after fully dissolved; weighing 3.15 g of DNS (3,5-dinitrosalicylic acid), adding the DNS to the above solution, and heating to make the DNS fully dissolved; adding 2.5 ml of phenol after cooled down, adding 2.5 g of anhydrous sodium sulfite, stirring fully to blend uniformly, and adding distilled water to prepare 500 ml of solution which can be used after standing for 3 days.
[0035] (5) Preparation of solutions of the litchi chinensis pericarp extract mainly composed of polymer polyphenols: dissolving the litchi chinensis pericarp extract mainly composed of polymer polyphenols in 0.01 mol/L PBS buffer with pH=7.0 to prepare solutions of the litchi chinensis pericarp extract mainly composed of polymer polyphenols with various concentrations.
[0036] (II) Determination of Inhibitory Activity of the Litchi Chinensis Pericarp Extract Mainly Composed of Polymer Polyphenols on α-Amylase
[0037] Blank group: adding 0.9 ml of 0.01 mol/L PBS buffer with pH=7.0, adding 0.1 ml of α-amylase solution, blending uniformly, and incubating in a 37° C. thermotank with water bath for 10 minutes; adding 0.2 ml of starch solution to start reaction, incubating in a 37° C. thermotank for 10 minutes, adding 1 ml of DNS developer, blending uniformly, and incubating in a 95° C. thermotank for 5 minutes; cooling with running water, and determining OD value with a semi-automatic biochemical analyzer at a wavelength of 540 nm.
[0038] Determination group: adding 0.8 ml of 0.01 mol/L PBS buffer with pH=7.0, adding 0.1 ml of solutions of the litchi chinensis pericarp extract mainly composed of polymer polyphenols with different concentrations and 0.1 ml of α-amylase solution, blending uniformly, and incubating in a 37° C. thermotank with water bath for 10 minutes; adding 0.2 ml of starch solution to start reaction, incubating in a 37° C. thermotank for 10 minutes, adding 1 ml of DNS developer, blending uniformly, and incubating in a 95° C. thermotank for 5 minutes; cooling with running water, and determining OD value with a semi-automatic biochemical analyzer at a wavelength of 540 nm.
[0039] Control group: adding 0.8 ml of 0.01 mol/L PBS buffer with pH=7.0, adding 0.1 ml of solutions of the litchi chinensis pericarp extract mainly composed of polymer polyphenols with different concentrations and 0.1 ml of 0.01 mol/L PBS buffer with pH=7.0, blending uniformly, and incubating in a 37° C. thermotank with water bath for 10 minutes; adding 0.2 ml of starch solution to start reaction, incubating in a 37° C. thermotank for 10 minutes, adding 1 ml of DNS developer, blending uniformly, and incubating in a 95° C. thermotank for 5 minutes; cooling with running water, and determining OD value with a semi-automatic biochemical analyzer at a wavelength of 540 nm.
[0040] Calculating the inhibition ratio of the litchi chinensis pericarp extract mainly composed of polymer polyphenols with different concentrations on α-amylase, and the result is shown in
[0041] The above description of the disclosed embodiments enables those skilled in the art to realize or use the present invention. Many modifications to these embodiments will be apparent to those skilled in the art. The general principle defined herein can be realized in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to these embodiments shown herein, but will conform to the widest scope consistent with the principle and novel features disclosed herein.